The DOI matches its Crossref record; 565 of the 565 references it cites were found in a registry or an index.
2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
Open accessAbstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing, longitudinal, multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease (AD). The initial study, ADNI-1, enrolled 400 subjects with early mild cognitive impairment (MCI), 200 with early AD, and 200 cognitively normal elderly controls. ADNI-1 was extended by a 2-year Grand Opportunities grant in 2009 and by a competitive renewal, ADNI-2, which enrolled an additional 550 participants and will run until 2015. This article reviews all papers published since the inception of the initiative and summarizes the results to the end of 2013. The major accomplishments of ADNI have been as follows: (1) the development of standardized methods for clinical tests, magnetic resonance imaging (MRI), positron emission tomography (PET), and cerebrospinal fluid (CSF) biomarkers in a multicenter setting; (2) elucidation of the patterns and rates of change of imaging and CSF biomarker measurements in control subjects, MCI patients, and AD patients. CSF biomarkers are largely consistent with disease trajectories predicted by β-amyloid cascade (Hardy, J Alzheimer's Dis 2006;9(Suppl 3):151-3) and tau-mediated neurodegeneration hypotheses for AD, whereas brain atrophy and hypometabolism levels show predicted patterns but exhibit differing rates of change depending on region and disease severity; (3) the assessment of alternative methods of diagnostic categorization. Currently, the best classifiers select and combine optimum features from multiple modalities, including MRI, [(18)F]-fluorodeoxyglucose-PET, amyloid PET, CSF biomarkers, and clinical tests; (4) the development of blood biomarkers for AD as potentially noninvasive and low-cost alternatives to CSF biomarkers for AD diagnosis and the assessment of α-syn as an additional biomarker; (5) the development of methods for the early detection of AD. CSF biomarkers, β-amyloid 42 and tau, as well as amyloid PET may reflect the earliest steps in AD pathology in mildly symptomatic or even nonsymptomatic subjects and are leading candidates for the detection of AD in its preclinical stages; (6) the improvement of clinical trial efficiency through the identification of subjects most likely to undergo imminent future clinical decline and the use of more sensitive outcome measures to reduce sample sizes. Multimodal methods incorporating APOE status and longitudinal MRI proved most highly predictive of future decline. Refinements of clinical tests used as outcome measures such as clinical dementia rating-sum of boxes further reduced sample sizes; (7) the pioneering of genome-wide association studies that leverage quantitative imaging and biomarker phenotypes, including longitudinal data, to confirm recently identified loci, CR1, CLU, and PICALM and to identify novel AD risk loci; (8) worldwide impact through the establishment of ADNI-like programs in Japan, Australia, Argentina, Taiwan, China, Korea, Europe, and Italy; (9) understanding the biology and pathobiology of normal aging, MCI, and AD through integration of ADNI biomarker and clinical data to stimulate research that will resolve controversies about competing hypotheses on the etiopathogenesis of AD, thereby advancing efforts to find disease-modifying drugs for AD; and (10) the establishment of infrastructure to allow sharing of all raw and processed data without embargo to interested scientific investigators throughout the world.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SNPs in and around candidate genes including APOE, BIN1, SORL1, and CR1 have been associated with traits including medial temporal lobe atrophy and cortical thickness [225–228]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [225]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A. (2013) · Nature · doi:10.1038/nature12415 · Cited by 151
RetractedMcKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 1×
“Diagnosis of MCI using National Institute on AgingAlzheimer’s Association criteria The NIA-AA criteria for MCI due to AD recently incorporated the use of biomarkers for both amyloid deposition (CSF Ab42, (11)C-PiB-PET) and neuronal injury (CSF tau, hippocampal and whole brain atrophy on MRI, FDG-PET) in addition to cl…”
MethodSelf-citationSperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Self-citationda Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,015
Research works printed but not linked: 14
- Trojanowski J, 2004, Searching for the biomarkers of Alzheimer's, Pract Neurol, 3, 30
- Mueller SG, 2006, Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative, Cogn Dement, 5, 56
- Cruchaga C, 2009, SNPs in the regulatory subunit of calcineurin are associated with CSF tau protein levels, brain mRNA levels, Alzheimers Dement, 5, P471
- LiY WangY WuG ShiF ZhouL LinW et al.Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.Neurobiol Aging (in press).
- Thambisetty M, 2012, Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification byAPOEGenotype, Biol Psychiatry, 73, 334
- Weiner MW, 2012, The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception, Alzheimers Dement, 8, S1
- 10.1016/j.bbadis.2011.09.008 · DOI
- 10.1016/j.neuroimage.2009.05.056 · DOI
- 10.3389/fnins.2012.00115 · DOI
- 10.1007/s11682-012-9184-1 · DOI
- 10.1007/s11682-012-9196-x · DOI
- 10.3389/fgene.2011.00073 · DOI
- 10.1016/j.neuroimage.2011.03.077 · DOI
- 10.2174/156720512802455331 · DOI
Cited by
Sorted by citations
Items 201–300 of 348
Almubark, I., Alsegehy, S., Jiang, X., & Chang, L. (2020) · IEEE Conference on Big Data and Analytics (ICBDA) · doi:10.1109/icbda50157.2020.9289741 · Cited by 8
Les nouveaux critères de la Maladie d’Alzheimer – Perspective gériatrique*
Molin, P., & Rockwood, K. J. (2016) · Canadian Geriatrics Journal · doi:10.5770/cgj.19.242 · Cited by 13
Li, X., Initiative, O. B. O. A. D. N., Chu, S.-G., Shen, X.-N., Hou, X.-H., Xu, W., Ou, Y.-N., Dong, Q., Tan, L., & Yu, J.-T. (2019) · Aging · doi:10.18632/aging.102435 · Cited by 7
Xiao, C.-Y., Ma, Y., Zhao, Y., Liu, J.-Y., & Tan, L. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.02.007 · Cited by 8
Pan, N., Liu, S., Ge, X., Zheng, Y., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251314785 · Cited by 7
Self-citationNassanga, R., Nakasujja, N., Kaddumukasa, M., Jones, S. E., Sajatovic, M., & Kawooya, M. G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0305788 · Cited by 7
Yashin, A. I., Wu, D., Arbeev, K. G., Bagley, O., Akushevich, I. V., Duan, M., Yashkin, A. P., & Ukraintseva, S. V. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111477 · Cited by 7
Multivariate functional mixed model with MRI data: An application to Alzheimer's disease
Zou, H., Xiao, L., Zeng, D., Luo, S., & Initiative, A. D. N. (2023) · Statistics in Medicine · doi:10.1002/sim.9683 · Cited by 7
Self-citationClassification of MRI and psychological testing data based on support vector machine.
Yang, W., Chen, X., Cohen, D. S., Rosin, E. R., Toga, A. W., Thompson, P. M., & Huang, X. (2017) · PubMed · Cited by 7
Self-citationThe ADNI Administrative Core: Ensuring ADNI's success and informing future AD clinical trials
Nosheny, R. L., Miller, M. J., Conti, C., Flenniken, D., Ashford, M. T., Diaz, A., Fockler, J., Truran, D., Kwang, W., Kanoria, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14311 · Cited by 6
Self-citationHuang, Y., Meng, Q., Evans, H. L., Lober, W. B., Cheng, Y., Qian, X., Liu, J. Y., & Huang, S. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.07.003 · Cited by 6
Tropea, T. F., & Chen‐Plotkin, A. S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090834 · Cited by 5
Perumal, P., Chander, N., Anitha, K. V., Reddy, J. R., & Muthukumar, B. (2016) · The Journal of Advanced Prosthodontics · doi:10.4047/jap.2016.8.3.187 · Cited by 6
Neurodegenerative Diseases - Molecular Mechanisms and Current Therapeutic Approaches
Tunalı, N. E. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.83153 · Cited by 6
Bernick, C. B., Shan, G., Bennett, L. L., Alberts, J. L., & Cummings, J. L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.605318 · Cited by 6
Cao, L., Initiative, A. D. N., Wang, H.-F., Tan, L., Sun, F.-R., Tan, M., Tan, C., Jiang, T., Yu, J., & Tan, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7797 · Cited by 7
Self-citationSerial position effects rapidly distinguish Alzheimer’s from frontotemporal dementia
Kloth, N., Lemke, J., Wiendl, H., Meuth, S. G., Duning, T., & Johnen, A. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09662-w · Cited by 8
EEG Biomarker for Alzheimer’s Disease
Algın, D. İ., Adapınar, D. Ö., & Erdinç, O. O. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93711 · Cited by 6
Soldan, A., Gazes, Y., & Stern, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.06319-7 · Cited by 6
Incorporating spatial–anatomical similarity into the VGWAS framework for AD biomarker detection
Huang, M., Yu, Y., Yang, W., Feng, Q., & Initiative, A. D. N. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz401 · Cited by 6
Self-citationKawarabayashi, T., Terakawa, T., Takahashi, A., Hasegawa, H., Narita, S., Sato, K., Nakamura, T., Seino, Y., Hirohata, M., Baba, N., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190023 · Cited by 6
Longitudinal ComBat: A Method for Harmonizing Longitudinal Multi-scanner Imaging DataPreprint
Beer, J. C., Tustison, N. J., Cook, P. A., Davatzikos, C. A., Sheline, Y. I., Shinohara, R. T., Linn, K. A., & Initiative, A. D. N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/868810 · Cited by 6
Self-citationXiao, X., Liu, J., Guo, L., Xue, K.-Z., Wang, S.-J., Liu, F., Qin, W., Yu, C.-S., & Liang, M. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121642 · Cited by 5
Yeung, M. K.-C., Lee, T., & Chan, A. S.-Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220130 · Cited by 5
Zhang, X.-H., Tan, C., Zheng, Y.-W., Ma, X., Gong, J.-N., Tan, L., & Xu, W. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.235 · Cited by 5
Maksimovich, I. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815305-5.00038-5 · Cited by 5
Li, J., Yao, Z., Duan, M., Liu, S., Li, F., Hai-Yang, Z., Xia, Z., Huang, L., & Zhou, F. (2020) · IEEE Access · doi:10.1109/access.2020.3025828 · Cited by 5
Mohamed, A. Z., Lagopoulos, J., Nasrallah, F. A., & Shan, Z. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.03.029 · Cited by 5
Ning, K., Bouchard-Cannon, P., Yu, J., Shenoi, S., Wang, L., Initiative, A. D. N., & Sarkar, J. (2024) · Brain Informatics · doi:10.1186/s40708-024-00218-x · Cited by 9
Self-citationMotter, J. N., Pelton, G. H., D’Antonio, K., Rushia, S. N., Pimontel, M. A., Petrella, J. R., Garcon, E., Ciovacco, M., Sneed, J. R., Doraiswamy, P. M., et al. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4955 · Cited by 5
Raamana, P. R., Strother, S. C., Initiative, A. D. N., & Initiative, A. D. N. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/170381 · Cited by 6
Self-citationGraessel, E., & Lauer, N. (2023) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2023.04.004 · Cited by 4
Clayton, D., Coimbra, A., Faraji, F., Bengtsson, T., Honigberg, L. A., Cho, W. C. S., Paul, R. H., & de Crespigny, A. J. (2021) · Neuroimage Reports · doi:10.1016/j.ynirp.2021.100055 · Cited by 4
Guo, Y., Zou, H., Alam, M. S., & Luo, S. (2025) · Statistics in Medicine · doi:10.1002/sim.70105 · Cited by 4
The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
Serrano, E., Sanz, P. G., & Barrantes, F. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_29 · Cited by 4
Elshatoury, H., Cruciani, F., Zumerle, F., Storti, S. F., Altmann, A., Lorenzi, M., Anbarjafari, G., Menegaz, G., & Galazzo, I. B. (2021) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi50953.2021.9508487 · Cited by 4
Biomarkers of Alzheimer’s Disease
Saeed, U., Swardfager, W., Black, S. E., & Masellis, M. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-2414-6_8 · Cited by 4
A New Method for Diagnosing Alzheimer's Disease and Monitoring Its Severity Using FDG-PET
Yuksel, C., Rasi, R., & Güveniş, A. (2022) · Medical Technologies Congress (TIPTEKNO) · doi:10.1109/tiptekno56568.2022.9960196 · Cited by 4
Classification and Structuring of DL-Based Method for Finding Alzheimer’s Disease through MRI Images
Tripathi, T., & Kumar, R. (2024) · IEEE International Conference on Computing, Power and Communication Technologies (IC2PCT) · doi:10.1109/ic2pct60090.2024.10486064 · Cited by 4
Maksimovich, I. V. (2022) · Medical Research Archives · doi:10.18103/mra.v10i7.2938 · Cited by 4
Randomized Deep Learning Methods for Clinical Trial Enrichment and Design in Alzheimer's Disease
Ithapu, V. K., Singh, V., & Johnson, S. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810408-8.00020-1 · Cited by 4
Maksimovich, I. V. (2018) · World Journal of Neuroscience · doi:10.4236/wjns.2018.84036 · Cited by 4
Using eZIS to Predict Progression from MCI to Dementia in Three Years
Pai, Y., Matsuda, H., & Pai, M. (2024) · Diagnostics · doi:10.3390/diagnostics14161780 · Cited by 3
Zinkunegi, A. J., Bruno, D., Betthauser, T. J., Langhough, R. E., Asthana, S., Chin, N. A., Hermann, B. P., Johnson, S. C., & Mueller, K. D. (2023) · The Clinical Neuropsychologist · doi:10.1080/13854046.2023.2223389 · Cited by 3
Atrophy of the cholinergic regions advances from early to late mild cognitive impairment
Lai, Y.-L. L., Hsu, F., Yeh, S.-Y., Kuo, Y.-T., Lin, H.-H., Lin, Y., Kuo, L., Chen, C., Liu, H.-S., & Initiative, A. D. N. (2024) · Neuroradiology · doi:10.1007/s00234-024-03290-6 · Cited by 3
Self-citationTalemi, M. D., Tapak, L., Haghi, A. R., Ahghari, P., Moradi, S., & Afshar, S. (2023) · Avicenna Journal of Medical Biochemistry · doi:10.34172/ajmb.2475 · Cited by 3
Yao, W., Initiative, A. D. N., Chen, H., Luo, C., Sheng, X., Zhao, H., Xu, Y., & Bai, F. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201376 · Cited by 3
Self-citationHe, B., Wang, L., Xu, B., & Zhang, Y. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135765 · Cited by 3
Potter, W. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.196 · Cited by 3
Initial Results in Alzheimer's Disease Progression Modeling Using Imputed Health State Profiles
Fleet, B. D., Deller, J. R., & Goodman, E. D. (2016) · International Conference on Computational Science and Computational Intelligence (CSCI) · doi:10.1109/csci.2016.0010 · Cited by 3
Choi, H., Yang, Y., Han, H. J., Jeong, J. H., Park, M. Y., Kim, Y. B., Jo, K. D., Choi, J.-Y., Kang, K.-H., Kang, H., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180565 · Cited by 3
Angelopoulos, S. P. (2021) · Hawaii International Conference on System Sciences (HICSS) · doi:10.24251/hicss.2021.414 · Cited by 3
Zhang, Y., Wei, Q., Wang, Y., Zeng, L., Sun, S., Wu, Y., Ren, C., Wang, F., Chen, G., & Cao, L. (2022) · Brain and Behavior · doi:10.1002/brb3.2817 · Cited by 2
Predicting MMSE Score from Finger-Tapping MeasurementPreprint
Ma, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/817338 · Cited by 3
Koike, S., Tanaka, S. C., Okada, T., Aso, T., Asano, M., Maikusa, N., Morita, K., Okada, N., Fukunaga, M., Uematsu, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.05.076273 · Cited by 3
Ning, K., Bouchard-Cannon, P., Yu, J., Shenoi, S., Wang, L., Initiative, A. D. N., & Sarkar, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.17.484832 · Cited by 3
Self-citationYu, F., Todd, M. S., Salisbury, D. L., Maxfield, M., Pruzin, J. J., Joseph, R. P., Su, Y., Li, D., Baena, E., & Coon, D. W. (2025) · Trials · doi:10.1186/s13063-025-09040-0 · Cited by 3
Dimensionality Reduction: Foundations and Applications in Clinical Neuroscience
Kernbach, J. M., Ort, J., Hakvoort, K., Clusmann, H., Delev, D., & Neuloh, G. (2021) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-030-85292-4_8 · Cited by 2
Ehrlich, D., Dunzinger, A., Malsiner‐Walli, G., Grün, B., Topakian, R., Hodolič, M., Kainz, E., & Pichler, R. (2021) · Radiology and Oncology · doi:10.2478/raon-2021-0051 · Cited by 3
Li, Y., Xie, Y., Xu, Y., Zhang, N., Li, G., & Ju, S. (2022) · European Radiology · doi:10.1007/s00330-022-08659-w · Cited by 2
Ezeala‐Adikaibe, B., Oti, B. B., Ohaegbulam, S. C., Ndubuisi, C. A., & Okwudili, O. (2022) · West African journal of radiology · doi:10.4103/wajr.wajr_23_21 · Cited by 2
Exosomes as nanocarrier for Neurotherapy: Journey from application to challenges
Ale, Y., & Nainwal, N. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106312 · Cited by 2
The potential of circulating autoantibodies in the early diagnosis of Alzheimer’s disease
Yin, W., & Stover, C. M. (2017) · AIMS Allergy and Immunology · doi:10.3934/allergy.2017.2.62 · Cited by 2
Gareau, D. S., Rochakim, N., Choudhury, A., Bamkole, M. A., Snuderl, M., Zou, J., Yaroslavsky, A. N., Jacques, S. L., Strickland, S., Krueger, J. G., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1163447 · Cited by 2
Porter, T., Armstrong, A. M., Milicic, L., Vacher, M. A., Fernandez, S., O’Brien, E. K., Doré, V., Bourgeat, P., Shishegar, R., Xia, Y., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7540786/v1 · Cited by 2
Sufficient component cause simulations: an underutilized epidemiologic teaching tool
Kezios, K., & Hayes‐Larson, E. (2023) · Frontiers in Epidemiology · doi:10.3389/fepid.2023.1282809 · Cited by 2
Dybing, K. M., Gao, S., Saykin, A. J., Risacher, S. L., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251401201 · Cited by 1
Self-citationYu, H., Lee, H., Lee, M., Kim, D., Pirpamer, L., Duering, M., Moy, S., Helmer, K. G., Kim, R. E. Y., & Initiative, A. D. N. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1672133 · Cited by 1
Self-citationPeng, Y., Zhan, Y., & Zhang, Q. (2025) · Psychology Research and Behavior Management · doi:10.2147/prbm.s552134 · Cited by 2
Guo, F., Sheng, Z.-H., Li, T., Huang, L.-Y., Li, B., Wang, X.-J., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251415349 · Cited by 1
Self-citationWei, H., Zhang, C., Wen, P., Kong, M., & Ba, M. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70293 · Cited by 1
Nassanga, R., Nakasujja, N., Mubuuke, A. G., Lwere, K., Kawooya, M. G., Ocan, M., & Kaddumukasa, M. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-114801 · Cited by 1
BRAINS: A Retrieval-Augmented System for Alzheimer’s Detection and Monitoring
Gupta, R. D., Morol, M. K., Fahad, N., Hosain, M. T., Choya, S. B. Z., & Hossen, M. J. (2025) · International Conference on Machine Learning and Applications · doi:10.1109/icmla66185.2025.00224 · Cited by 3
Effective distance-based multi-modality feature selection for Alzheimer’s disease identification
Wang, M., Ye, T., Ma, C., Li, X., Liu, M., & Zhang, D. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.110582 · Cited by 1
Abugabah, A. (2026) · Journal of imaging informatics in medicine · doi:10.1007/s10278-026-02005-y · Cited by 1
Hirayama, A., & Soga, T. (2016) · Wiley-VCH eBooks · doi:10.1002/9783527693801.ch10 · Cited by 1
Molecular Imaging and Precision Medicine in Dementia and Movement Disorders
Mallik, A. K., Drzezga, A. E., & Minoshima, S. (2016) · PET Clinics · doi:10.1016/j.cpet.2016.08.003 · Cited by 1
High-Field 3 T Imaging of Alzheimer’s Disease
Caligiuri, M. E., Cherubini, A., Scarabino, T., & Sabatini, U. (2017) · Springer eBooks · doi:10.1007/978-3-319-44174-0_18 · Cited by 1
Tang, J., Chen, Q., Fu, Z., Liang, Y., Xu, G., Zhou, H., & He, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26839 · Cited by 1
ZhiXiong, Y., He, Z., Zou, X., Han, J., Jiang, L., Lan, Z., Cai, Y., Feng, R., Su, X.-Q., XiaoHui, H., et al. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-1241 · Cited by 1
Zhang, C., Li, B., Ng, K. P., Huang, G., Wang, X., Kong, M., & Ba, M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1547394 · Cited by 1
High-Field 3 T Imaging of Alzheimer Disease
Luccichenti, G., Péran, P., Cherubini, A., Giugni, E., Scarabino, T., Hagberg, G. E., & Sabatini, U. (2006) · Springer eBooks · doi:10.1007/3-540-31776-7_17 · Cited by 1
GPU Accelerated Browser for Neuroimaging Genomics
Initiative, A. D. N., Zigon, B., Li, H., Yao, X., Fang, S., Hasan, M. A., Yan, J., Moore, J. H., Saykin, A. J., & Shen, L. (2018) · Neuroinformatics · doi:10.1007/s12021-018-9376-y · Cited by 1
Self-citationАндреевич, П. В., Солодовников, В. И., Sinitsyn, V. E., Михайловна, П. Е., Koberskaya, N. N., Gridin, V. N., & Yakhno, N. N. (2019) · Journal of radiology and nuclear medicine · doi:10.20862/0042-4676-2018-99-6-295-304 · Cited by 1
Using big data methods to understand Alzheimer’s disease
Warren, S. L., Moustafa, A. A., & Alashwal, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821334-6.00004-1 · Cited by 1
Collaborative efforts to prevent Alzheimer's disease
Touchon, J., Rosenbaum, J., Aisen, P. S. S., Andrieu, S., Carrillo, M. C., Ceccaldi, M. P., Dartiques, J., Feldman, H., Gabelle, A., Isaac, M., et al. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0961-9 · Cited by 1
Self-citationGareau, D. S., Bamkole, M. A., Snuderl, M., Thomas, C., Bayin, N. S., Placantonakis, D. G., Zou, J., Yaroslavsky, A. N., Dietz, M. P., Jacques, S. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.17.444224 · Cited by 1
Treatment Approaches to Neurocognitive Disorders
Moukaddam, N. J., Bejjani, C., & Shah, A. A. (2016) · Psychiatric Annals · doi:10.3928/00485713-20160105-01
Rodríguez, A. C. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/16526
Hippocampus Gray Matter Atrophy Happens More Seriously in AD Female Patients
Beheshti, I., Matsuda, H., Farokhian, F., & Yang, C. (2016) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2016.910b023
Ong, K., & Woodward, M. (2017) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1177/0004867417694748
Biomarkers of Alzheimer’s Disease
Saeed, U., Swardfager, W., Black, S. E., & Masellis, M. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-0370-7_8-1
How to improve success rates of the compounds acting on CNS using biomarkers.
Katsumata, S. (2017) · Nihon yakurigaku zasshi. Folia pharmacologica Japonica · doi:10.1254/fpj.149.148
Jogia, J. (2017) · OBM Neurobiology · doi:10.21926/obm.neurobiol.1702006
Potential Biomarkers for Alzheimer’s Disease Screened in a Small Brazilian Population
Bonini, J. S., Fermino, B. L., Wouk, J., Fabbri, R., da Silva, W. C. F. N., Vellosa, J. C. R., Patrzyk, L. H., Fiebrantz, A. K. B., & Ivanski, F. (2017) · Hospice and Palliative Medicine International Journal · doi:10.15406/hpmij.2017.01.00022
Amyloid Plaques in Alzheimer’s Disease
Franceschi, A. M., & Matthews, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-65106-4_124
Dietary Patterns, Foods and Beverages in Age-Related Cognitive Performance and Dementia
Dreher, M. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-59180-3_18
Capizzano, A. A., Moritani, T., Jacob, M., & Warren, D. E. (2018) · Wiley eBooks · doi:10.1002/9781118772034.ch8
Ong, K. T. (2018) · OBM Geriatrics · doi:10.21926/obm.geriatr.1803011
Metadata
- Authors
- Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Luthman, J., Morris, J. C., Petersen, R. C., Saykin, A. J., Shaw, L., Shen, L., Schwarz, A., Toga, A. W., Trojanowski, J. Q., & Initiative, A. D. N.
- Affiliations
- San Francisco VA Medical Center (US)
- University of California San Diego (US)
- University of California, Davis (US)
- Washington University in St. Louis (US)
- Biogen (United States) (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- University of California, Berkeley (US)
- Eisai (United States) (US)
- Indiana University Indianapolis (US)
- University of Pennsylvania (US)
- Eli Lilly (United States) (US)
- University of Southern California (US)
- Corresponding author
- Weiner, Michael W.
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2015-06
- Volume
- 11
- Issue
- 6
- Pages
- e1-120
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC5469297
- OpenAlex
- W1797408175
- Cited by
- 348
- References
- 565
- Citations by year
- 2026: 27 · 2025: 22 · 2024: 28 · 2023: 18 · 2022: 18 · 2021: 43 · 2020: 28 · 2019: 38 · 2018: 36 · 2017: 45 · 2016: 33 · 2015: 11
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion, other-oa)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Biogen
- Synarc
- TauRx Pharmaceuticals
- Bayer HealthCare
- Servier
- Ipsen
- National Institutes of Health (5u01ag024904-10)
- National Institute on Aging (U01-AG-024904, P30AG010129, P30AG010133, R01AG012975, R01AG030048, P30AG036468, P30AG010124, P01AG009215, P01AG017586, U01AG010483, U01AG029213, P50AG005681, R01AG016381, P01AG003991, R01AG019771, RC2AG036535, P01AG019724)
- National Cancer Institute (P30CA093373)
- National Institute of General Medical Sciences (R01GM088336)
- National Institute of Neurological Disorders and Stroke (P50NS053488)
- National Center for Research Resources (UL1RR024146, R25RR026008)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, Alzheimer's Disease Neuroimaging Initiative
- MeSH terms
- Alzheimer Disease, Brain, Humans, Radionuclide Imaging, Multicenter Studies as Topic, Biomarkers, Nootropic Agents, Early Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
